Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International Phase 4 Field Study to Analyse the Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Breast Cancer (EORTC QLQ-BR23 Update- EORTCQLQ BR45)

NCT04018235 is registered in ClinicalTrials.gov with Helios University Hospital Wuppertal as lead sponsor.

NCT NCT04018235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04018235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International Phase 4 Field Study to Analyse the Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Breast Cancer (EORTC QLQ-BR23 Update- EORTCQLQ BR45)
Lead sponsor
Helios University Hospital Wuppertal
Phase
Observational
Overall status
Completed
Start date
June 14, 2019
Completion date
December 17, 2021
Enrollment
576 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, quality of life